{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:05:39Z","timestamp":1762542339326,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.prro.2014.09.004","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T03:48:27Z","timestamp":1414640907000},"page":"e215-e222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques"],"prefix":"10.1016","volume":"5","author":[{"given":"Colin T.","family":"Murphy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Ruth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark K.","family":"Buyyounouski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Uzzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Plimack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kutikov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David Y.T.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric M.","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2014.09.004_bb0005","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/014107688307600606","article-title":"Bowel disease after radiotherapy","volume":"76","author":"Schofield","year":"1983","journal-title":"J R Soc Med"},{"key":"10.1016\/j.prro.2014.09.004_bb0010","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1097\/00007611-198907000-00027","article-title":"Early cervical cancer coexistent with idiopathic inflammatory bowel disease","volume":"82","author":"Hoffman","year":"1989","journal-title":"South Med J"},{"key":"10.1016\/j.prro.2014.09.004_bb0015","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ijrobp.2010.02.040","article-title":"Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer","volume":"80","author":"Sharma","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.prro.2014.09.004_bb0020","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.ijrobp.2005.07.970","article-title":"Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial","volume":"64","author":"Pollack","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.prro.2014.09.004_bb0025","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.brachy.2011.05.011","article-title":"Biochemical and clinical experience with real-time intraoperatively planned permanent prostate brachytherapy","volume":"11","author":"Lubbe","year":"2012","journal-title":"Brachytherapy."},{"key":"10.1016\/j.prro.2014.09.004_bb0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0360-3016(97)00234-4","article-title":"Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales","volume":"38","author":"Hanlon","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2014.09.004_bb0035","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0360-3016(00)00700-8","article-title":"Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial","volume":"48","author":"Storey","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2014.09.004_bb0040","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0360-3016(99)00374-0","article-title":"Acute and late toxicity of patients with inflammatory bowel disease undergoing irradiation for abdominal and pelvic neoplasms","volume":"46","author":"Willett","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2014.09.004_bb0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0360-3016(01)01629-7","article-title":"Acute and late radiotherapy toxicity in patients with inflammatory bowel disease","volume":"51","author":"Song","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2014.09.004_bb0050","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.brachy.2012.04.008","article-title":"Toxicity after (125)I prostate brachytherapy in patients with inflammatory bowel disease","volume":"12","author":"Pai","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2014.09.004_bb0055","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S0360-3016(99)00091-7","article-title":"Rectal cancer and inflammatory bowel disease: Natural history and implications for radiation therapy","volume":"44","author":"Green","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2014.09.004_bb0060","doi-asserted-by":"crossref","unstructured":"Tiersten A, Saltz LB. Influence of inflammatory bowel disease on the ability of patients to tolerate systemic fluorouracil-based chemotherapy. J Clin Oncol. 996;14:2043-2046.","DOI":"10.1200\/JCO.1996.14.7.2043"},{"key":"10.1016\/j.prro.2014.09.004_bb0065","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0360-3016(97)00583-X","article-title":"Prostate brachytherapy in patients with inflammatory bowel disease","volume":"40","author":"Grann","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2014.09.004_bb0070","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ijrobp.2006.05.027","article-title":"Low-dose rate prostate brachytherapy is well tolerated in patients with a history of inflammatory bowel disease","volume":"66","author":"Peters","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850014002471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850014002471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:18:44Z","timestamp":1761819524000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850014002471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1879850014002471"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2014.09.004","relation":{},"ISSN":["1879-8500"],"issn-type":[{"type":"print","value":"1879-8500"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2014.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Society for Radiation Oncology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}